Skip to content
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
Financial reports
November 10, 2023
Interim report January – September 2023 for CombiGene AB (publ)
Read more
August 25, 2023
Interim report January – June 2023 for CombiGene AB (publ)
Read more
May 12, 2023
Interim report January – March 2023 for CombiGene AB (publ)
Read more
April 26, 2023
CombiGene AB (publ) publishes annual report for 2022
Read more
February 17, 2023
Year-end report January-December 2022 CombiGene AB (Publ)
Read more
November 11, 2022
Interim report January – September 2022 for CombiGene AB (publ)
Read more
August 25, 2022
Interim report January – June 2022 for CombiGene AB (publ)
Read more
May 12, 2022
Interim report January – March 2022 for CombiGene AB (publ)
Read more
Search
Search
2023
November 10, 2023
Interim report January – September 2023 for CombiGene AB (publ)
August 25, 2023
Interim report January – June 2023 for CombiGene AB (publ)
May 12, 2023
Interim report January – March 2023 for CombiGene AB (publ)
April 26, 2023
CombiGene AB (publ) publishes annual report for 2022
February 17, 2023
Year-end report January-December 2022 CombiGene AB (Publ)
2022
November 11, 2022
Interim report January – September 2022 for CombiGene AB (publ)
August 25, 2022
Interim report January – June 2022 for CombiGene AB (publ)
May 12, 2022
Interim report January – March 2022 for CombiGene AB (publ)
April 27, 2022
Annual Report 2021
February 17, 2022
Year-end report January-December 2021 CombiGene AB (Publ)
2021
November 12, 2021
Interim report January – September for CombiGene AB (publ)
August 20, 2021
Interim report January – June 2021 for CombiGene AB (publ)
May 12, 2021
Interim report January – March 2021 for CombiGene AB (publ)
May 4, 2021
Annual Report 2020
2020
It seems we can't find what you're looking for.
2019
August 21, 2019
Interim Report January – June 2019 for CombiGene AB (publ)
May 17, 2019
Interim Report January-March 2019
February 14, 2019
Year-end statement January-December 2018
2018
November 14, 2018
Interim Report January – September 2018
August 22, 2018
Interim Report January – june 2018
May 3, 2018
Interim Report January-March 2018
May 2, 2018
Annual Report 2017
January 29, 2018
Year-end statement January-December 2017
January 23, 2018
CombiGene AB (publ) presents the year-end statement for 2017 at an earlier date than planned
2017
November 1, 2017
Interim Report January-September 2017
October 26, 2017
CombiGene AB (publ) presents interim report for third quarter 2017 at an earlier date than planned
August 21, 2017
Interim Report January-June 2017
April 18, 2017
CombiGene Annual Report 2016
January 10, 2017
CombiGene proposes a rights issue and to present the year-end statement at an earlier date than planned
